- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 15/117 - Nucleic acids having immunomodulatory properties, e.g. containing CpG-motifs
Patent holdings for IPC class C12N 15/117
Total number of patents in this class: 751
10-year publication summary
58
|
71
|
71
|
71
|
52
|
79
|
65
|
67
|
57
|
19
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Index Pharmaceuticals AB | 49 |
18 |
AIM ImmunoTech Inc. | 51 |
18 |
The Trustees of the University of Pennsylvania | 4304 |
17 |
Dynavax Technologies Corporation | 116 |
14 |
Idera Pharmaceuticals, Inc. | 82 |
14 |
Northwestern University | 3357 |
13 |
Targimmune Therapeutics AG | 35 |
13 |
Tallac Therapeutics, Inc. | 23 |
13 |
President and Fellows of Harvard College | 5942 |
12 |
Rheinische Friedrich-Wilhelms-Universität Bonn | 202 |
12 |
Curevac SE | 262 |
12 |
The Regents of the University of California | 19803 |
11 |
Glaxosmithkline Biologicals S.A. | 1634 |
10 |
Arizona Board of Regents on behalf of Arizona State University | 2570 |
10 |
City of Hope | 977 |
10 |
Modernatx, Inc. | 1258 |
10 |
Gilead Sciences, Inc. | 2026 |
9 |
The Board of Trustees of the Leland Stanford Junior University | 6347 |
8 |
Mayo Foundation for Medical Education and Research | 3183 |
8 |
Daiichi Sankyo Company, Limited | 1849 |
8 |
Other owners | 511 |